Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-004679
Filing Date
2023-03-10
Accepted
2023-03-10 17:06:41
Documents
2
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 form3-03102023_100331.html 3  
1 form3-03102023_100331.xml 3 8654
2 ex24-03102023_100331.htm EX-24 4313
  Complete submission text file 0001415889-23-004679.txt   14264
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Buckbee Kevin K (Reporting) CIK: 0001968528 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35565 | Film No.: 23724612